Literature DB >> 9845164

Acquisition and storage deficits in multiple sclerosis.

J DeLuca1, E A Gaudino, B J Diamond, C Christodoulou, R A Engel.   

Abstract

This study examined whether verbal and visual memory impairments in multiple sclerosis (MS) are attributable to deficits in acquisition, storage, or retrieval. Volunteers with MS (n = 40) and healthy controls (n = 20) rehearsed a word list and a checkerboard pattern using a selective reminding procedure until two consecutive error-free trials were attained. Recall and recognition were assessed after 30 min and 90 min (and 1 week for verbal material) delays. The MS group required significantly more trials to attain criterion on both learning tests. Once equated for acquisition, both groups performed similarly on verbal recall and recognition. However the MS group performed significantly worse on measures of visual recall and recognition. The results suggest that the verbal memory impairment in MS is due to deficient acquisition, while the visual memory impairment in MS is attributable to deficits in acquisition and storage.

Entities:  

Mesh:

Year:  1998        PMID: 9845164     DOI: 10.1076/jcen.20.3.376.819

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  37 in total

1.  Memory impairment in multiple sclerosis is due to a core deficit in initial learning.

Authors:  John Deluca; Victoria M Leavitt; Nancy Chiaravalloti; Glenn Wylie
Journal:  J Neurol       Date:  2013-07-06       Impact factor: 4.849

2.  FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.

Authors:  Danielle Barry; Marsha E Bates; Erich Labouvie
Journal:  Appl Neuropsychol       Date:  2008

3.  Pain is associated with prospective memory dysfunction in multiple sclerosis.

Authors:  Ashley K Miller; Michael R Basso; Philip J Candilis; Dennis R Combs; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2014-10-23       Impact factor: 2.475

4.  High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.

Authors:  Katherine A Koenig; Ken E Sakaie; Mark J Lowe; Jian Lin; Lael Stone; Robert A Bermel; Erik B Beall; Stephen M Rao; Bruce D Trapp; Micheal D Phillips
Journal:  Magn Reson Imaging       Date:  2013-01-05       Impact factor: 2.546

5.  Verbal episodic memory in 426 multiple sclerosis patients: impairment in encoding, retrieval or both?

Authors:  H Brissart; E Morele; C Baumann; M Debouverie
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

6.  Regional lobar atrophy predicts memory impairment in multiple sclerosis.

Authors:  Ralph H B Benedict; Robert Zivadinov; Dominic A Carone; Bianca Weinstock-Guttman; Jeff Gaines; Cosimo Maggiore; Jitendra Sharma; Maria-Antonietta Tomassi; Rohit Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

7.  Neuropsychological deficits but not coping strategies are related to physical disability in multiple sclerosis.

Authors:  Claus G Haase; Marc Lienemann; Pedro M Faustmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

8.  An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.

Authors:  Nancy D Chiaravalloti; Nancy B Moore; Olga M Nikelshpur; John DeLuca
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

9.  NIH Toolbox Cognitive Battery (NIHTB-CB): the NIHTB Pattern Comparison Processing Speed Test.

Authors:  Noelle E Carlozzi; David S Tulsky; Nancy D Chiaravalloti; Jennifer L Beaumont; Sandra Weintraub; Kevin Conway; Richard C Gershon
Journal:  J Int Neuropsychol Soc       Date:  2014-06-24       Impact factor: 2.892

10.  Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Authors:  Sarah A Morrow; Audrey Smerbeck; Kara Patrick; Diane Cookfair; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2012-09-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.